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Risk Factors for Falls in Adults With Rheumatoid
Arthritis: A Prospective Study
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Objective. To investigate the association between potential risk factors and falls in community-dwelling adults with
rheumatoid arthritis (RA).
Methods. We followed patients for 1 year of followup in a prospective cohort study with monthly falls calendars and
telephone calls. Lower extremity muscle strength, postural stability, number of swollen and tender joints, functional
status, history of falling, fear of falling, pain, fatigue, medication, and use of steroids were assessed as risk factors for falls.
Results. A total of 386 women and 173 men with RA (n 559) ages 18–88 years completed baseline assessments and 535
participants (96%) completed 1-year followup. Bivariate logistic regression showed that falls risk was not associated with
age or sex. Multivariate logistic regression revealed that a history of multiple falls in the previous 12 months was the most
signiﬁcant predictive risk factor (odds ratio [OR] 5.3, 95% conﬁdence interval [95% CI] 2.3–12.3). The most signiﬁcant
modiﬁable risk factors were swollen and tender lower extremity joints (OR 1.7, 95% CI 1.1–2.7), psychotropic medication
(OR 1.8, 95% CI 1.1–3.1), and fatigue (OR 1.13, 95% CI 1.02–1.2).
Conclusion. Adults with RA are at high risk of falls. In clinical practice, high-risk fall patients with RA can be identiﬁed
by asking whether patients have fallen in the past year. Important risk factors highlighted in this study include swollen
and tender lower extremity joints, fatigue, and use of psychotropic medications.
INTRODUCTION
Adults with rheumatoid arthritis (RA) have an increased
risk of falls (1–3). Suggested reasons for this include im-
paired muscle strength, postural instability, fatigue, joint
pain, and reduced functioning (2–5). The falls also lead to
an increased risk of hip fractures due to disease-related
reduced bone mass (5,6). Other fall consequences include
serious injuries, hospital admission or admission to care
homes, fear of falling, and reduced quality of life.
Estimates of the proportion of people with RA who fall
annually range from 10–54% (1–12), and this high variability
may be due to the sample selection (women only, small
samples, or frail older patients), inconsistent deﬁnitions or
no deﬁnitions of falls, and use of different assessment mea-
sures. The risk factors for falls in patients with RA that have
been drawn from previous studies include tender joint count
(11,12), swollen joint count (2,4), pain in lower extremities
(9), pain intensity (4,7,8), Health Assessment Questionnaire
(HAQ) disability score (4,9,11,12), low levels of physical
activity (4), impaired general health (4,12), use of antidepres-
sants (3), impaired vision (4), impairment in both walking
and rising (3), walk time (8), impaired balance (2), number of
medications (3), number of comorbidities (8), and 1-year
history of falls (7). Some of these risk factors are common to
older people (e.g., impaired vision, previous history of a fall,
and number and types ofmedications) (13), but others appear
to be disease speciﬁc (e.g., swollen or tender joints, pain, and
increased HAQ disability scores).
To date, there has not been a sufﬁciently large prospec-
tive study of adults of all ages with RA to provide a
comprehensive investigation of the fall risk factors associ-
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ated with RA. The identiﬁcation of predictive and poten-
tially modiﬁable risk factors is essential for the develop-
ment of effective falls prevention strategies. The aim of
this study was to identify fall risk factors in adults with
RA.
SUBJECTS AND METHODS
A consecutive sample of eligible patients was recruited
from 4 rheumatology clinics in the Northwest of England.
A variety of different clinics were accessed to ensure peo-
ple with different levels of disease severity were invited to
participate. All participants were ages 18 years with a
diagnosis of RA based on the 2010 American College of
Rheumatology/European League Against Rheumatism
classiﬁcation criteria for RA (14). Participants were ex-
cluded from the study if they were age 18 years or if they
did not have the mental or physical capacity to give in-
formed consent (assessed by a research nurse). This study
was conducted with the approval of the National Research
Ethics Committee (reference 08/H1009/41).
Measurements were taken at baseline between the
months of August 2008 and March 2009, and participants
were followed up for falls and injuries for 1 year using
preaddressed, prepaid daily falls calendars (posted
monthly) and monthly followup telephone calls.
Data collection. Variables considered important in
causing or predicting falls were assessed at baseline by
trained research nurses experienced in undertaking joint
counts.
RA status was assessed by the number of swollen/tender
joints (shoulders, elbows, wrists, metacarpophalangeal
joints, proximal interphalangeal joints, and knees), the
Disease Activity Score in 28 joints (DAS28), and the Stan-
ford Arthritis Centre HAQ. The DAS28 has been exten-
sively validated for use in clinical trials and practice (15).
It provides scores for the number of swollen and tender
joints, erythrocyte sedimentation rate, and a visual analog
scale (VAS) global disease scale. The total DAS28 ranges
from 0–10 and indicates the current activity of RA. Ac-
cepted cutoffs are 5.1 for high disease activity and 3.2 for
low disease activity. The HAQ is a self-administered ar-
thritis-speciﬁc instrument that measures patients’ percep-
tions of difﬁculties in performing activities in daily living
and the need for equipment and physical assistance to
perform tasks, and has been extensively tested for validity
and reliability (16).
Fear of falling was recorded using the Short Falls Efﬁ-
cacy Scale-International (Short FES-I). The Short FES-I is a
validated and reliable 7-item tool that measures fear of
falling related to a range of activities (17).
Falls risk was measured by the validated Falls Risk
Assessment Tool, which includes questions on the history
of any fall in the previous year, taking 4 prescribed
medications, and diagnosis of stroke or Parkinson’s dis-
ease (18). Vision was assessed using a self-reported ques-
tion (which gives a score of 0–4) (19). Patients were also
asked questions about levels of pain and fatigue using VAS
(20,21) and about any comorbidities (number and type)
and previous fractures, surgery, or joint replacement(s) (4),
and veriﬁed using medical records. Medical records were
also used to check history and previous medication use,
including steroid use (11).
Lower extremity muscle strength and balance were as-
sessed using the Chair Stand Test (22) and the Four-Test
Balance Scale (23). For the Chair Stand Test, participants
were instructed to stand up and down from a chair as
quickly as possible 5 times with their arms folded. The
time taken to complete was recorded. The Four-Test Bal-
ance Scale comprised 4 timed static balance tasks of in-
creasing difﬁculty using different positioning of the par-
ticipants’ feet. Participants were scored 0 for unsuccessful,
1 if they could only stand with their feet together, 2 if they
could only complete a semitandem stand, 3 if they could
complete a tandem stand, and 4 for participants who could
complete a one-leg stand. The participant must hold each
position for 10 seconds before progressing to the next more
challenging task.
The Prevention of Falls Network Europe (ProFaNE) def-
inition of “an unexpected event in which participants
come to rest on the ground, ﬂoor, or other lower level” was
used to identify falls, rather than trips or stumbles (24).
Participants who reported a fall, failed to return a falls
calendar, or ﬁlled in the calendar incorrectly were con-
tacted by telephone each month. The methods of Campbell
et al were used to collect information about the fall event
during the followup telephone calls (25), as recommended
by Schwenk and colleagues (26). Data included the date of
the fall, a self-reported description of how the fall oc-
curred, consequences and injuries, and health care utili-
zation (e.g., hospital admission, medical assistance, phys-
iotherapy).
Statistical analysis. The ProFaNE consensus group–
recommended guidance on fall data analysis was utilized
for analysis of the data (24). Analysis of variance (ANOVA)
was used to test for differences between the groups of
nonfallers, single fallers, and multiple fallers. Levene’s test
for homogeneity of variance was initially applied (27).
When homogeneity of variances was met (P greater than
0.05), ANOVA was undertaken and Tukey’s post hoc tests
were used to compare the differences between pairs of
groups. In cases when Levene’s test was not met (P less
Signiﬁcance & Innovations
● Lower extremity muscle strength, postural stabil-
ity, number of swollen and tender joints, func-
tional status, history of falling, fear of falling, pain,
fatigue, medication, and use of steroids were as-
sessed as risk factors for falls in adults with rheu-
matoid arthritis (RA).
● Important risk factors found in this study include
swollen and tender lower extremity joints, fatigue,
and use of psychotropic medications.
● Adults with RA, regardless of age, are at high risk
of falls.
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than or equal to 0.05), Welch’s test (27) was used to deter-
mine overall signiﬁcance between the groups, and Dun-
nett’s T3 post hoc tests (27) were used to compare between
pairs of groups.
Chi-square tests of trend were used as appropriate for
categorical data to examine differences in groups of non-
fallers, single fallers, and multiple fallers. Binary logistic
regression was used to calculate odds ratios (ORs) and
95% conﬁdence intervals (95% CIs) for age, sex, and all
fall risk–associated variables, with occurrence of falls dur-
ing the study as the outcome. Variables were initially
examined using bivariate analyses to estimate associations
for each risk factor with fall outcomes. To avoid an under-
powered logistic regression analysis, the 3 groups (nonfall-
ers, single fallers, and multiple fallers) were combined into
2 groups (nonfallers and all fallers) and a limited number
of explanatory variables were selected based on statistical
signiﬁcance (P less than 0.05). These variables were se-
lected using the Hosmer-Lemeshow approach (28). The
selected variables were entered into 2 multivariate analy-
ses, using binary multivariate logistic regression to build
predictive and explanatory risk models. In addition to
understanding the best predictive risk factors, it is clini-
cally important to understand the risk factors that can
potentially be modiﬁed to enable an effective falls preven-
tion strategy to be implemented. Therefore, an explanatory
risk factor model excluding a 12-month history of falls as
well as a predictive risk factor model were added to the
analysis to explore the potentially modiﬁable reasons for
falls. Multicollinearity was assessed using a variance in-
ﬂation factor (VIF)10. Statistical analysis was performed
using SPSS, version 16.0 (29).
RESULTS
Subject characteristics. The baseline characteristics of
the sample are provided in Table 1. The mean  SD age of
Table 1. Baseline demographics and 1-year prestudy characteristics*
Total
(n  535)
Nonfaller
group
(n  340)
Single
faller
group
(n  94)
Multiple
faller
group
(n  101)
Overall
P
Age, mean  SD years 62  13.6 62  12.7 66  11.7 61  12.7 0.12†
Women, no. (%) 386 (69.1) 235 (69.1) 68 (72.3) 70 (69.3) 0.83‡
No. of swollen joints (range 0–28), mean  SD 4.7  6.3 4.5  6.1 3.8  5.0 5.8  7.0 0.09†
No. of tender joints (range 0–28), mean  SD 5.3  6.9 5.0  6.6 4.2  5.5 7.0  8.0 0.02†
DAS28 score (range 0–10), mean  SD 4.1  1.6 3.9  1.6 4.1  1.3 4.5  1.5 0.002†
Use of psychotropic medication, no. (%) 105 (18.8) 47 (13.8) 20 (21.3) 34 (33.7)  0.001‡
Taking 4 types of medications each day, no. (%) 431 (77.1) 247 (72.4) 83 (88.3) 82 (81.2) 0.003‡
Taking steroids at baseline, no. (%) 117 (20.9) 61 (17.9) 21 (22.3) 28 (27.7) 0.03‡
History of stroke or Parkinson’s disease, no. (%) 38 (6.8) 18 (5.3) 5 (5.3) 13 (12.9) 0.02‡
VAS pain score (range 0–10), mean  SD 3.85  2.7 3.5  2.6 3.8  2.6 5.0  2.4  0.001†
VAS fatigue score (range 0–10), mean  SD 4.7  2.8 4.2  2.7 5.2  2.9 5.8  2.2  0.001†
History of fall in previous 12 months, no. (%) 232 (43.4) 108 (31.8) 53 (56.4) 71 (70.3)  0.001‡
History of no falls in previous 12 months, no. (%) 303 (56.6) 232 (68.2) 41 (43.6) 30 (29.7) –
History of single fall in previous 12 months 116 (21.7) 58 (17.1) 36 (38.3) 22 (21.8) –
History of multiple falls in previous 12 months 116 (21.7) 50 (14.7) 17 (18.1) 49 (48.5) –
History of fractures, no. (%) 228 (40.8) 127 (37.4) 39 (41.5) 53 (52.5) 0.008‡
History of injuries from previous falls (range 0–6), mean  SD 1.6  1.5 – 1.8  1.1 2.5  1.4  0.001†
Poor vision (registered blind, very poor, or poor), no. (%) 46 (8.6) 26 (7.6) 8 (8.5) 12 (11.9) 0.87‡
No. of comorbidities (range 0–10), mean  SD 2.0  1.9 1.9  1.9 2.1  1.9 2.2  2.3 0.36†
Previous surgery, no. (%) 408 (73.1) 246 (72.4) 66 (70.2) 79 (78.2) 0.63‡
Painful feet, no. (%) 432 (77.3) 260 (76.5) 72 (76.6) 84 (83.2) 0.17‡
No. of joint replacements (range 0–4), no. (%) 125 (22.5) 76 (22.5) 22 (23.4) 24 (23.8) 0.74‡
Symptoms of feeling dizzy or unsteady, no. (%) 370 (66.2) 209 (61.5) 64 (68.1) 80 (79.2) 0.01‡
Fear of falling: Short FES-I score (range 7–28), mean  SD 15.3  6.5 14.4  6.4 15.6  17.8 17.8  5.6  0.01†
HAQ score (range 1–4), mean  SD 2.4  0.9 2.3  0.8 2.5  0.8 2.8  0.8  0.001†
Fail at each level of the Four-Test Balance Scale, no. (%)
Unsuccessful (0) 39 (7.0) 19 (5.6) 6 (6.4) 11 (10.9) –
Feet together stand (1) 13 (2.2) 5 (1.5) 2 (2.1) 3 (3.0) –
Semitandem stand (2) 216 (38.6) 127 (37.4) 42 (44.7) 38 (37.6) –
Tandem stand (3) 116 (20.8) 67 (19.7) 20 (21.3) 25 (24.8) –
One-leg stand (4) 175 (31.3) 122 (35.9) 24 (25.5) 24 (23.8) 0.008‡
Ability to complete 5 chair stands, no. (%) 484 (86.6) 307 (90.3) 83 (88.3) 76 (75.2)  0.001‡
Time taken to perform 5 chair stands, mean  SD seconds 20.9  12.2 19.8  11.2 22.8  14.1 24.2  13.7 0.02†
* DAS28  Disease Activity Score in 28 joints; VAS  visual analog scale; Short FES-I  Short Falls Efﬁcacy Scale-International; HAQ  Health
Assessment Questionnaire.
† Signiﬁcant differences were evaluated by one-way analysis of variance.
‡ Signiﬁcant differences were evaluated by the chi-square test.
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the male participants was 62  11.0 years and the mean 
SD age of the female participants was 61.9  13.6 years.
There were more than twice as many women (n  386
[69%]) as men recruited to the study and 68% of the
participants were married (n  378). The majority of the
participants described themselves as white and British
(n 544 [97%]). More than half were retired from employ-
ment (n  327 [59%]), with only one-quarter in employ-
ment (n  134 [24%]). The mean DAS28 score of the
participants (4.1, mode 3.9) fell within the moderate dis-
ease activity range (3.3–5.1). The majority of the partici-
pants had comorbidities, with hypertension (n  149
[27%]), respiratory disease (n  92 [16%]), cardiovascular
disease (n  82 [15%]), and osteoarthritis (n  78 [14%])
being the most common. There were 19 variables used in
the analysis, of which there were a total of 16 missing
values among the 535 participants, leading to a missing
data rate of 0.18%.
Among the 535 participants with RA, 195 (36%; 95% CI
32–41%) reported a fall during the 1-year followup. In the
1-year followup, there were 340 nonfallers (64%), 94 sin-
gle fallers (those who fell once, 18%), and 101 multiple
fallers (those who fell more than once, 19%). In the year
preceding entry to the study, there were 317 nonfallers
(57%), 120 single fallers (21%), and 122 multiple fallers
(22%). The probability of a 1-year followup fall signiﬁ-
cantly increased (P  0.001) if the participant fell during
the previous 12 months. Of those with a 1-year history of
falls, 124 (53.4%) reported a 1-year followup fall, whereas
of those with no 1-year history of falls, only 71 (23.4%)
reported study falls.
Multiple fallers had a signiﬁcantly higher mean Short
FES-I score than single fallers (mean difference 2.2; P 
0.03) and nonfallers (mean difference 3.5; P  0.001).
There were no signiﬁcant differences between the mean
Short FES-I score in the groups of single fallers and non-
fallers (mean difference 1.3; P  0.19). These results sug-
gest that multiple fallers have signiﬁcantly higher levels of
fear of falling compared to single fallers or nonfallers;
however, in clinical terms, these differences are small.
VAS pain scores were signiﬁcantly higher in multiple
fallers (mean difference 1.5; 95% CI 0.83–2.20, P  0.001)
than in nonfallers and single fallers (mean difference 1.1;
95% CI 0.28–2.01, P  0.006). However, there were no
signiﬁcant differences between single fallers and nonfall-
ers in baseline VAS pain scores (mean difference 0.4; P 
0.44).
VAS fatigue scores were signiﬁcantly higher in single
fallers (mean difference 1.1; P  0.005) and multiple fall-
ers (mean difference 1.6; P  0.001) than in nonfallers.
However, there were no signiﬁcant differences between
single fallers and multiple fallers in VAS fatigue scores
(mean difference 0.6; P  0.34).
Mean DAS28 scores were signiﬁcantly higher in multi-
ple fallers (mean difference 0.6; P  0.001) than in non-
fallers. However, there were no signiﬁcant differences be-
tween single fallers and multiple fallers (mean difference
0.5; P  0.07) and between single fallers and nonfallers in
DAS28 scores (mean difference 0.2; P  0.61).
Single fallers had a higher mean HAQ score than non-
fallers (mean difference 0.2; P  0.06), and this was bor-
derline signiﬁcant. Multiple fallers had a signiﬁcantly
higher mean HAQ score than single fallers (mean differ-
ence 0.3) and nonfallers (mean difference 0.5; P  0.04).
Compared to nonfallers and single fallers at followup, at
baseline, those experiencing multiple falls were more
likely to take 4 types of medications (P  0.013), receive
psychotropic medications (P  0.001), report feeling dizzy
or unsteady (P  0.01), and have a history of stroke or
Parkinson’s disease (P  0.02); were less likely to be able
to complete the Chair Stand Test than nonfallers (P 
0.001); and were less likely to be able to complete the
semitandem stand, the tandem stand, or the one-leg stand
(P  0.008), take steroid medication (P  0.03), or have a
history of fracture (P  0.008) (Table 1).
Risk factors. The results comparing all fallers with non-
fallers using logistic regression analyses are shown in Ta-
ble 2. The variables were classiﬁed into groups of demo-
graphic, medical, self-report/functional ability, and
postural risk factors.
Medical risk factors. There were no associations found
between the number of tender joints and falls. Reporting
any swollen or tender lower extremity joints (hip, knee, or
ankle; feet not included) doubled the risk of falling during
the followup period. The DAS28 score was another pre-
dictor of falls that could be useful in clinical practice (OR
1.2). Taking psychotropic medications more than doubled
the odds of falling. Polypharmacy was a signiﬁcant predic-
tor of falls; taking 4 medications more than doubled the
risk of falling. Taking steroids at baseline increased the
risk of falling by half, as did a history of previous frac-
ture(s). There were no associations found between a his-
tory of stroke or Parkinson’s disease and falls. Both the
VAS pain and VAS fatigue scores showed similar positive
predictive values for falling, with the risk raised by 20%
for every 1-point increase in the score. A positive self-
reported history of falls in the previous 12 months at
baseline was a strong predictor of falls. Reporting a single
fall in the previous 12 months at baseline more than tri-
pled the risk of falling during the reporting period of our
prospective study, and reporting multiple falls more than
quadrupled the risk. Reporting 12-month previous injuri-
ous falls at baseline (OR 1.3) and a history of fracture(s)
(OR 1.5) were also strong predictors of falls.
Self-report/functional ability risk factors. The Short
FES-I score values range from 7 (no fear of falling) to 28
(very fearful of falling), and for each 1-unit increase there
was a 10% increase in odds of falls. The bivariate analyses
demonstrated that for each additional point attained in the
ﬁnal HAQ score (range 1.00–4.00), the risk of falling in-
creased by 70%.
Postural risk factors. The ORs between the groups in the
Four-Test Balance Scale increased as the groups became
more impaired. The odds of falling was 2.3 times higher
for participants who could not complete the Four-Test
Balance Scale at all and 2.5 times higher for those who
could only complete the feet together stand; however, the
95% CIs spanned agreement in this scale, possibly due to
smaller numbers of participants. A symptom of feeling
dizzy or unsteady was also a strong predictor of falls with
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participants, with positive reports having an 80% greater
risk of falling than those without.
There was an association found with those who were
able to complete the Chair Stand Test with an OR of 0.48,
which means that there was a protective association for
falls over the 1-year followup for those who were able to
complete the test. Therefore, those able to complete the
Chair Stand Test were half as likely to fall as those unable
to complete the test. The time taken to complete the Chair
Stand Test varied from 4–104 seconds. For every addi-
tional second taken to complete the test, there was an
increased risk of falling of 2%.
Multivariate analysis of predictive risk factors. Multi-
variate logistic regression was used to build a predictive
model that could be useful to gauge fall risk. Due to the
limited number of participants who fell (n  195), only a
selected number of variables could be included in a mul-
tivariate regression in order to avoid model overspeciﬁca-
tion. The following variables were included in this multi-
variate analysis based on their statistical signiﬁcance in
the bivariate analysis: swollen or tender lower extremity
joints, taking psychotropic medications, taking 4 medi-
cations, a history of fracture or injuries, the ability and
time taken to complete the Chair Stand Test, the ability to
complete the Four-Test Balance Scale, feeling dizzy or
unsteady, fear of falling (Short FES-I score), history of a
single fall, history of multiple falls, DAS28 score, taking
steroids, pain, fatigue, and HAQ score. Multivariate logis-
tic regression analysis initially showed that the results
from the ability to complete the Chair Stand Test variable
were highly correlated with the other variables, causing
spurious model estimates (VIF 10) (22). Therefore, the
ability to complete the Chair Stand Test variable was ex-
cluded from the analysis. The same variables (excluding
the ability to complete the Chair Stand Test but not the
time to complete the Chair Stand Test) were entered into
multivariate logistic regression analyses to build the best
predictive model of falls. The results from the multivariate
analysis for predictive risk factors are shown in Table 3.
Predictive risk model. The ﬁnal model included all 16
selected risk factor variables in predicting the occurrence
of falls during the study, and accurately explained 71% of
the variation in the data. Statistically signiﬁcant variables
were the 12-month history of a single fall (OR 3.6, 95% CI
1.8–7.3; P  0.001) or multiple falls (OR 5.3, 95% CI
2.3–12.3; P  0.001), swollen or tender lower extremity
joints (OR 1.7, 95% CI 1.1–2.8; P  0.02), increasing VAS
fatigue (OR 1.11, 95% CI 1.0–1.3; P  0.03), and taking 4
types of medications (OR 1.8, 95% CI 1.5–3.1).
Explanatory risk factor model. A multivariate logistic
regression analysis of the risk factors excluding a 12-
month history of fall(s) was conducted to explore the po-
tential reasons for falls. In addition to understanding the
best predictive risk factors, it is clinically important to
understand the risk factors that can potentially be modi-
ﬁed to enable an effective falls prevention strategy to be
implemented. Although a history of a single fall or multi-
Table 2. Associations between fall risk factors and
fallers using bivariate binary logistic regression (all
fallers n  195/nonfallers n  340)*
OR (95% CI)
Demographic risk factors
Sex
Male Referent
Female 1.1 (0.7–1.6)
Age (range 18–88 years) 1.0 (0.99–1.02)
Medical risk factors
No. of tender joints (range 0–28) 1.0 (0.98–1.04)
Swollen or tender lower extremity
joints
No Referent
Yes 2.0 (1.3–2.8)
DAS28 score (range 0.1–8) 1.2 (1.1–1.3)
Use of psychotropic medications
No Referent
Yes 2.4 (1.5–3.7)
Taking 4 types of medications
No Referent
Yes 2.1 (1.3–3.3)
Taking steroids at baseline
No Referent
Yes 1.5 (1.0–2.4)
History of stroke or Parkinson’s
disease
No Referent
Yes 1.8 (0.9–3.6)
No. of comorbidities (range 0–10) 1.0 (0.97–1.2)
VAS pain score (range 0–10) 1.2 (1.1–1.2)
VAS fatigue score (range 0–10) 1.2 (1.1–1.3)
History of falls in previous 12 months
0 falls Referent
1 fall 3.3 (2.1–5.1)
2 falls 4.3 (2.7–6.8)
History of fracture
No Referent
Yes 1.5 (1.04–2.1)
History of injuries from previous falls
(range 0–6)
1.3 (1.1–1.6)
Self-report/functional ability risk factors
Short FES-I score (range 7–28) 1.1 (1.03–1.1)
HAQ score (range 1.00–4.00) 1.7 (1.4–2.1)
Postural risk factors
Four-Test Balance Scale
Unsuccessful (0) 2.3 (1.1–4.7)
Feet together stand (1) 2.5 (0.7–9.1)
Semitandem stand (2) 1.6 (1.0–2.5)
Tandem stand (3) 1.7 (1.0–2.8)
One-leg stand (4) Referent
Symptoms of feeling dizzy or unsteady
No Referent
Yes 1.8 (1.2–2.6)
Ability to complete the Chair Stand
Test
No Referent
Yes 0.48 (0.29–0.8)
Time taken for the Chair Stand Test
(n  484, range 4–104 seconds)
1.02 (1.01–1.04)
* OR  odds ratio; 95% CI  95% conﬁdence interval; DAS28 
Disease Activity Score in 28 joints; VAS visual analog scale; Short
FES-I  Short Falls Efﬁcacy Scale-International; HAQ  Health
Assessment Questionnaire.
Fall Risk Factors in RA 1255
ple falls was found to be the best independent predictor of
falls, this model does not help clinicians to prevent the
initial fall, and a history of a single fall or multiple falls
can be considered a marker of poor mobility or frailty (30).
Therefore, a history of a single fall or multiple falls was
excluded from the analysis due to its lack of utility in
designing an intervention. The 12 variables included in
the multivariate logistic regression were chosen in ad-
vance from the 18 signiﬁcant variables examined in the
bivariate analysis. DAS28 and VAS pain scores were in-
cluded as covariates and swollen or tender lower extrem-
ity joints, taking 4 medications, HAQ score, Short FES-I
score, use of psychotropic medications, taking steroids at
baseline, time taken to complete the Chair Stand Test, the
Four-Test Balance Scale, symptoms of feeling dizzy or
unsteady, and the VAS fatigue score were also included as
the most clinically relevant for purposes of intervention.
The multivariate analysis for explanatory risk factors is
shown in Table 4.
Explanatory risk model. The multivariate logistic re-
gression analysis for the explanatory fall risk factors
showed that having any swollen or tender lower extremity
joints (hip, knee, and ankle), taking psychotropic medica-
tions, and increasing VAS fatigue produced the best ﬁtting
risk factor model. The amount of variation explained by
the explanatory risk factor model due to 12 variables was
68%.
DISCUSSION
In this study, 36% of participants ages 18 years reported
falling at least once in the 1-year followup period. This is
slightly higher than the 30% reported by older people ages
65 years living in the community (13,31). Due to the high
risk of falls and the associated increased risk of fractures,
it is important to highlight factors that may be modiﬁed to
prevent falls in this group.
Falls in adults with RA are not just random events, but
may be predicted and possibly prevented by assessing and
treating a number of independent risk factors. Asking for a
history of falls will highlight those at high risk of further
falls, followed by the assessment of swollen and tender
lower extremity joints (hip, knee, or ankle), taking psycho-
tropic medications, and VAS fatigue levels. We suggest
that targeting interventions toward these risk factors could
reduce the burden of falls in patients with RA; however,
further studies are required to conﬁrm this. Patients
should be prescribed psychotropic medications with cau-
tion, with regular reviews, and should take them no longer
than necessary (32). In older people, gradual withdrawal of
psychotropic medication reduced the rate of falls (13), and
this approach may also be effective in patients with RA.
High fatigue levels are common in adults with RA and
have been linked to pain and depression (21,33); however,
there is some evidence that fatigue levels fall with disease-
modifying antirheumatic drugs (DMARDs) and anti–tumor
necrosis factor therapy (34,35). Swollen and tender lower
extremity joints may be improved through good multidis-
ciplinary management of the patient. Drug management of
RA to reduce swollen and tender joints is complex and
includes the use of DMARDs, steroids, and biologic agents.
From this study, the use of steroids was associated with an
increased risk of falls, and for these reasons and due to
their long-term effects, it is recommended that they are
used with caution.
Table 4. Results from a multivariate analysis based on
12 explanatory risk factors of all fallers (n  195) versus
nonfallers (n  340) excluding history of falls*
OR (95% CI)
Swollen or tender lower extremity joints 1.7 (1.1–2.7)†
DAS28 score 0.9 (0.8–1.1)
Use of psychotropic medications 1.8 (1.1–3.1)†
Taking 4 types of medications 1.6 (0.96–2.8)
Taking steroids at baseline 1.2 (0.7–2.1)
VAS pain score 1.02 (0.92–1.1)
VAS fatigue score 1.13 (1.02–1.2)†
Fear of falling: Short FES-I score 1.004 (0.95–1.06)
HAQ score 1.11 (0.7–1.8)
Four-Test Balance Scale 1.0 (0.8–1.3)
Symptoms of feeling dizzy or unsteady 1.1 (0.7–1.7)
Time taken for the Chair Stand Test 1.002 (0.08–1.02)
* OR  odds ratio; 95% CI  95% conﬁdence interval; DAS28 
Disease Activity Score in 28 joints; VAS visual analog scale; Short
FES-I  Short Falls Efﬁcacy Scale-International; HAQ  Health
Assessment Questionnaire.
† Signiﬁcant.
Table 3. Results from a multivariate analysis based on
16 predictive risk factors of all fallers (n  195) versus
nonfallers (n  340)*
OR (95% CI)
Swollen or tender lower extremity joints 1.7 (1.1–2.8)†
DAS28 score (range 0.1–8) 0.9 (0.8–1.1)
Use of psychotropic medications (yes/no) 1.6 (0.9–2.9)
Taking 4 types of medications (yes/no) 1.8 (1.5–3.1)†
Taking steroids at baseline (yes/no) 1.3 (0.8–2.3)
VAS pain score (range 0–10) 1.02 (0.9–1.1)
VAS fatigue score (range 0–10) 1.11 (1.0–1.3)†
12-month history of a single fall (yes/no) 3.6 (1.8–7.3)†
12-month history of multiple falls
(yes/no)
5.3 (2.3–12.3)†
A history of fracture (yes/no) 1.3 (0.8–1.9)
A history of injuries from previous falls
(yes/no)
0.8 (0.6–1.1)
Short FES-I score (range 7–28) 1.0 (0.9–1.0)
HAQ score (range 1.00–4.00) 1.2 (0.7–2.0)
Four-Test Balance Scale (range 0–4) 1.0 (0.8–1.3)
Symptoms of feeling dizzy or unsteady
(yes/no)
0.9 (0.5–1.5)
Time taken to complete the Chair Stand
Test, seconds
0.99 (0.98–1.02)
* OR  odds ratio; 95% CI  95% conﬁdence interval; DAS28 
Disease Activity Score in 28 joints; VAS visual analog scale; Short
FES-I  Short Falls Efﬁcacy Scale-International; HAQ  Health
Assessment Questionnaire.
† Signiﬁcant.
1256 Stanmore et al
Poor balance and lower extremity strength were signiﬁ-
cantly associated with an increased risk of falling as ob-
served by previous RA studies (2,3,8). Speciﬁc exercises
adapted from a research-based falls prevention program
could be used to improve muscle strength and balance in
adults with RA and may reduce the risk of falls (36).
Exercise has been shown to reduce fatigue in adults with
RA, and may also improve depression and sleeping prob-
lems (37).
Increasing HAQ disability score and high DAS28 scores
were signiﬁcantly associated with an increased risk of
falling, as found in other studies (4,9,11,12). Fear of falling
was also associated with an increased risk of falls, as found
in other studies (8,9), and may result in avoidance of
activities and reduction of physical ability, which could
therefore increase the risk of future falls. Exercise may
improve fear of falling, the functional status of the HAQ
scores, and disease activity scores such as the DAS28;
however, further research is needed to investigate these
hypotheses (38).
In this study, the odds of falling were not signiﬁcantly
related to older age or female sex, which suggests that the
symptoms and risk factors associated with RA override the
risk factors usually associated with age and sex. This was
surprising, since in the general population, adults ages
65 years, in particular women, have signiﬁcantly more
falls than younger adults, and there is an increased trend
of falls in older ages (31,39,40). Hayashibara and col-
leagues also report that age was not associated with falls in
their small prospective study of 80 women with RA (2).
Older people in general are more prone to muscle weak-
ness due to inactivity and poor gait (31). Adults of all ages
with RA appear to have muscle weakness, and this may
result in the similar fall rates.
Strengths of the study include its prospective, longitu-
dinal design, high response rate, low attrition rate, and the
use of validated measurement tools to collect data on fall
risk factors. Attempts were made to recruit a representa-
tive sample of patients by attending a variety of outpatient
clinics that included nurse-led blood monitoring sessions,
primary care out of hours clinics, and rheumatology clin-
ics. However, it is likely that patients in this study had
more moderate to severe RA or more progressive disease
than those generally found in primary care, and some
caution should be given in applying these results to other
settings. It also would have been useful to have included
the foot joints in the RA disease activity assessment to
investigate the contribution of swollen/tender joints
within the lower extremity assessment. This may be of
particular importance given that foot pain is a risk factor
for falls in older people (41,42); however, a single question
on whether the participant currently experienced foot pain
was included in the baseline assessment due to the length
of time required to assess the foot joints within limited
resources. In addition, the HAQ, Short FES-I, Falls Risk
Assessment Tool, VAS pain, VAS fatigue, and data on
eyesight were self-reported by the participants and may be
subject to errors of recall.
Adults with RA are at high risk of falls. Health profes-
sionals can identify patients of particular risk of falls by
asking whether they have fallen in the past year. Patients
with RA would beneﬁt from a falls risk screening tool that
utilizes the most clinically relevant and signiﬁcant risk
factors associated with falling. We recommend for a
screening tool a 12-month history of falls, an assessment of
lower extremity swollen and tender joints, an assessment
of psychotropic medications, VAS fatigue and VAS pain
scores, the Four-Test Balance Scale to measure postural
stability, the Chair Stand Test to measure lower extremity
strength, the Short FES-I to measure fear of falling, and the
HAQ to measure functional ability. Future research should
consider a falls prevention program that incorporates ex-
ercises that speciﬁcally target lower extremity muscle
strength and challenge balance alongside a review of med-
ication, in particular the use of psychotropic medications.
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